Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other Non-Current Assets: 2019-2025

Historic Other Non-Current Assets for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $55,000.

  • Benitec Biopharma's Other Non-Current Assets fell 75.66% to $55,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $55,000, marking a year-over-year decrease of 75.66%. This contributed to the annual value of $578,000 for FY2024, which is 54.88% down from last year.
  • Latest data reveals that Benitec Biopharma reported Other Non-Current Assets of $55,000 as of Q1 2025, which was up 30.95% from $42,000 recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Other Non-Current Assets ranged from a high of $1.3 million in Q2 2023 and a low of $42,000 during Q4 2024.
  • Its 3-year average for Other Non-Current Assets is $505,111, with a median of $482,000 in 2024.
  • Per our database at Business Quant, Benitec Biopharma's Other Non-Current Assets soared by 8,911.11% in 2021 and then tumbled by 90.37% in 2024.
  • Benitec Biopharma's Other Non-Current Assets (Quarterly) stood at $499,000 in 2021, then fell by 5.41% to $472,000 in 2022, then dropped by 7.63% to $436,000 in 2023, then plummeted by 90.37% to $42,000 in 2024, then crashed by 75.66% to $55,000 in 2025.
  • Its last three reported values are $55,000 in Q1 2025, $42,000 for Q4 2024, and $482,000 during Q3 2024.